Corteva Q3 Earnings Call Highlights Brazil Woes and Outlook Cut
Corteva (CTVA) reported Q3 2026 adjusted earnings of $0.06/share, missing estimates, and revenues of $1.52B, also below consensus. The company cut its full-year EBITDA outlook to $1.1B-$1.13B due to Brazil's inventory issues, pricing pressure, and volume declines. CEO Luther Kissam and CFO Jeffrey Rudolph highlighted inventory normalization and cost reductions as priorities, with a focus on new products for growth. Full-year earnings are now projected at $0.76-$0.80/share.
How this was made

The 30-second read
Why it matters
The guidance cut is the primary new information, likely driving short‑term downside.
Market read
First report of a material earnings guidance reduction for a mid‑cap agribusiness firm, creating actionable downside risk.
What to watch
Cost‑reduction program and new product volume growth may offset Brazil weakness over the next quarters.
Background
Corteva reported Q3 2026 results with earnings miss and lowered full‑year outlook due to Brazil inventory and pricing issues.
Ticker impact
Corteva cut its full-year adjusted EBITDA outlook to $1.1‑$1.13 bn, citing Brazil weakness and $100 m inventory impact.
downward pressure as investors price in lower EBITDA and revenue guidance
The new guidance is materially lower than prior expectations and directly tied to a major market (Brazil), likely prompting a sell‑off.
Market effects
Agricultural chemicals sector faces earnings pressure from Brazil exposure.
Brazilian agribusiness outlook may weigh on related commodity and input stocks.
Potential ripple to global ag‑input supply chain and cost‑inflation dynamics.
Counterpoint
If Brazil inventory normalizes faster than expected, Corteva could rebound and exceed revised guidance.
Key entities
- CompanyCorteva, Inc.
US‑listed agricultural chemicals producer (CTVA).


